bluebird bio Inc (BLUE)
0.5651
+0.05
(+9.09%)
USD |
NASDAQ |
Oct 04, 16:00
0.5601
0.00 (0.00%)
After-Hours: 20:00
bluebird bio Shareholders Equity (Annual): 194.54M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 194.54M |
| December 31, 2022 | 134.33M |
| December 31, 2021 | 374.28M |
| December 31, 2020 | 1.355B |
| December 31, 2019 | 1.285B |
| December 31, 2018 | 1.885B |
| December 31, 2017 | 1.623B |
| Date | Value |
|---|---|
| December 31, 2016 | 869.44M |
| December 31, 2015 | 850.50M |
| December 31, 2014 | 491.26M |
| December 31, 2013 | 151.67M |
| December 31, 2012 | -55.75M |
| December 31, 2011 | -55.71M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
134.33M
Minimum
2022
1.355B
Maximum
2020
668.64M
Average
374.28M
Median
2021
Shareholders Equity (Annual) Benchmarks
| Vertex Pharmaceuticals Inc | 17.58B |
| Perspective Therapeutics Inc | 75.18M |
| Protalix BioTherapeutics Inc | 33.57M |
| Predictive Oncology Inc | 8.272M |
| Spectral AI Inc | -1.709M |